Home > Boards > US Listed > Medical - Drugs > Eli Lilly & Company (LLY)

NSAV news out on contract with LLY

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
MIKEY501 Member Profile
Member Level 
Followed By 961
Posts 74,769
Boards Moderated 45
Alias Born 07/30/10
160x600 placeholder
Lilly's CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung... PR Newswire (US) - 5/29/2020 9:07:00 PM
Lilly Receives U.S. FDA Approval of TAUVID™ (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer... PR Newswire (US) - 5/28/2020 7:17:00 PM
Statement from Lilly Chairman and CEO Dave Ricks on New Part D Senior Savings Model PR Newswire (US) - 5/26/2020 5:51:00 PM
Eli Lilly, Boehringer Ingelheim to Study Diabetes Drug Jardiance After Heart Attacks Dow Jones News - 5/26/2020 1:15:00 PM
Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibo... GlobeNewswire Inc. - 5/26/2020 10:11:01 AM
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance'... PR Newswire (US) - 5/26/2020 8:00:00 AM
Emgality® Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a H... PR Newswire (US) - 5/26/2020 6:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2020 9:09:24 AM
Results of GERAS-US Study Demonstrate Societal Cost Burden for Patients and Caregivers During Early Stages of Alzheimer's Dis... PR Newswire (US) - 5/19/2020 9:00:00 AM
Lilly Oncology Showcases Innovation in Cancer Research at ASCO 2020 PR Newswire (US) - 5/13/2020 5:00:00 PM
Mail-Order Drug Delivery Rises During Coronavirus Lockdowns Dow Jones News - 5/12/2020 7:29:00 AM
Drug Sales To Doctors Forced to Go Virtual -- WSJ Dow Jones News - 5/12/2020 3:02:00 AM
Drugmakers Overhaul the Sales Pitch Amid Coronavirus Lockdowns Dow Jones News - 5/11/2020 7:29:00 AM
Lilly Receives U.S. FDA Approval for Retevmo™ (selpercatinib), the First Therapy Specifically for Patients with Advanced RE... PR Newswire (US) - 5/8/2020 8:22:00 PM
FDA Approves Eli Lilly Subsidiary's Retevmo to Treat Certain Cancer Patients Dow Jones News - 5/8/2020 6:28:00 PM
Eli Lilly Says Higher Trulicity Doses Reduced A1C, Weight in People with Type 2 Diabetes Dow Jones News - 5/8/2020 3:45:00 PM
Higher investigational doses of Trulicity® (dulaglutide) meaningfully reduced A1C and body weight in people with type 2 diab... PR Newswire (US) - 5/8/2020 2:20:00 PM
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefine... PR Newswire (US) - 5/6/2020 7:30:00 PM
Lilly to Participate in UBS Virtual Global Healthcare Conference PR Newswire (US) - 5/5/2020 4:30:00 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/5/2020 1:59:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2020 1:47:20 PM
Lilly Declares Second-Quarter 2020 Dividend PR Newswire (US) - 5/4/2020 3:00:00 PM
Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 GlobeNewswire Inc. - 5/4/2020 9:14:00 AM
Lilly and Junshi Biosciences to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 PR Newswire (US) - 5/4/2020 8:00:00 AM
Shanghai Junshi Biosciences, Eli Lilly Ink Covid-19 Deal Dow Jones News - 5/3/2020 8:58:00 PM
MIKEY501 Member Level  Thursday, 12/21/17 03:43:58 PM
Re: NorFoster post# 87
Post # of 101 
NSAV news out on contract with LLY

NSAV 8-K officially Eli LillY contract VSRI 12/21/2017

Shanghai based Vital Strategic Research Institute (VSRI), has signed an agreement with Eli Lilly and Company. Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease (CVD) among newly diagnosed diabetes patients at increased risk of CVD in China

*******Copie of Contract*************

Ceo James Tilton wants to be clear with everything

Officieel op Sec EDGAR Search Results

OTC Reporting

Financial Highlights>>>> Revenu 2016 $ 21Billion !!! Netto income 2.7Billion

Eli Lilly builds $23B-plus Sales Forecast for 2017 on diabetes, cancer launches

**China spends $50 billion treating diabetes and related diseases every year,

**China, about 230 million people have cardiovascular disease.1

ELI LILLY AND CO Share price $ 87.00 Not a bad company to work with!!!

Never buy or sell based on anything I post - MY POSTS ARE ALWAYS JUST MY OPINION, regardless whether I include that in my post or not. I am not a financial advisor and anything I post should be considered only my opinion at that time.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist